Osteogenesis Imperfecta clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The primary objectives of the study are to identify a setrusumab dosing strategy in participants with OI and to evaluate the effect of setrusumab vs placebo on reduction in fracture rate.
San Francisco, California and other locations